Analysis

Earnings Preview: Darden Restaurants (DRI) looks headed for a strong second half

Darden Restaurants, Inc. (NYSE: DRI) delivered positive performance during the holiday season, which is probably the busiest time for the restaurant chain,

Nike is all set to report Q3 earnings on March 21. Here’s what to expect

Nike, Inc. (NYSE: NKE) is scheduled to publish third-quarter results next week, amid expectations for a year-over-year decline in profit. The sneaker

Lennar Corporation (LEN): A look at how the homebuilder performed in Q1 2024

Shares of Lennar Corporation (NYSE: LEN) rose over 2% on Friday. The stock has gained 51% over the past 12 months. The

Interviews

AlphaStreet's dedicated Earnings Call section is your one-source destination for all publicly listed earnings conference calls. Listen to CEOs/CFOs discuss their company's earnings reports while Wall Street Analysts ask (or grill) with their hard hitting questions.

Most Read

ADBE Earnings: Adobe Q1 2024 revenue and profit beat estimates

Design software maker Adobe Inc. (NASDAQ: ADBE) on Thursday reported an increase in first-quarter 2024 revenue and earnings. The results also surpassed analysts' forecasts. First-quarter revenues came in at $5.18

March 14, 2024

Earnings Preview: FedEx (FDX) likely to report higher revenue and profit for Q3

FedEx Corporation (NYSE: FDX) delivered positive earnings performance and margin expansion in the first half of fiscal 2024, despite lower revenues. The cargo giant has been on a path of

March 14, 2024

Key takeaways from Dollar General’s (DG) Q4 2023 earnings report

Shares of Dollar General Corporation (NYSE: DG) fell over 4% on Thursday despite the company delivering better-than-expected earnings results for the fourth quarter of 2023. The top and bottom line numbers

March 14, 2024

Research Summary

Ocean Biomedical, Inc. (NASDAQ: OCEA) Research Summary

Ocean Biomedical, Inc. (NASDAQ: OCEA) is a biotechnology company that works with leading researchers

Trxade Health Inc. (NASDAQ: MEDS) Q4 2023 Research Summary

Trxade Health, Inc. (NASDAQ: MEDS) operates as an integrated drug procurement and delivery platform,

Viewing Highlight
Loading...
Highlight
Close
Top